Group Leader: Prof. PharmDr. Martin Doležal, Ph.D.
- Synthesis and biological evaluation of new antibacterial derivatives, mainly those based on pyrazine and similar heterocycles
- Evaluation of antimycobacterial activity against M. tuberculosis H37Rv and non-tuberculous mycobacteria (M. avium, M. kansasii, M. smegmatis, M. aurum)
- Evaluation of antibacterial activity against selected G+ and G- bacterial pathogens, including drug-resistant strains
- Evaluation of antifungal activity against selected fungi and yeasts
- Determination of photosynthesis inhibitory activity of pyrazine derivatives (with potential use as herbicides)
- Pyrazine derivatives as abiotic elicitors (i.e. compounds capable of promoting synthesis of selected secondary metabolites in plants)
- Pyrazine-2-carboxamide derivatives as inhibitors of aminoacyl-tRNA synthetases
- In silico simulations of druglike molecules and their interactions to targets - docking, MD, QM
.gif.aspx "ccg_logo-(1).gif") |
.png.aspx "moe_slogan-(1).png") |
Using MOE (Molecular Operating Environment) software package developed by Chemical Computing Group, Montreal, QC, Canada.